Skip to main content
. 2016 Nov 14;7(51):83964–83975. doi: 10.18632/oncotarget.13336

Figure 4. Co-localization of Apaf-1 and caveolin (lipid raft marker) in B-cell Lymphoma.

Figure 4

Apaf-1 distribution is shown in both benign and DLBCL by immunohistochemistry. Benign and DLBCL section slides were de-paraffinized and stained with anti-Apaf-1-HRP or anti-Caveolin-HRP, followed by secondary anti-HRP.